Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Stage

Series A | Alive

About Curix

Developer of peptide modification methods. The company develops methods for modifying peptide drugs designed to increase their stability.

Curix Headquarter Location

Valby,

Denmark

45 36 44 2626

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.